By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



8 rue de la Croix Jarry

Paris    75013  France
Phone: 33-0-1-81-69-16-00 Fax: n/a




Company News
Cellectis (ALCLS) And Ohio State University, Through The Ohio State Innovation Foundation, Enter Into Licensing Agreement For Chimeric Antigen Receptor Technology Targeting Multiple Myeloma 1/13/2015 11:38:46 AM
Cellectis (ALCLS) Plans To Conduct Registered Initial Public Offering In The U.S. 1/9/2015 10:40:16 AM
Cellectis (ALCLS) Announces The Issuance By The USPTO Of A Patent Covering A Seminal Nuclease-Based “Gene Editing” Method 1/6/2015 2:34:32 PM
Cellectis Plant Sciences And Two Blades Foundation Announce The Execution Of A Cross-License Agreement On TAL Effector Nuclease Technologies 12/18/2014 10:48:43 AM
Cellectis (ALCLS) Announces Upcoming Presentations At The 56th Annual Meeting Of American Society of Hematology 11/24/2014 12:33:25 PM
Cellectis (ALCLS) Received Proceeds of €13 Million Through The Exercise Of Warrants 11/13/2014 11:10:33 AM
Cellectis (ALCLS): TALENTM Technology: Grant Of EP 2 510 096 By The European Patent Office 11/4/2014 10:37:26 AM
Cellectis (ALCLS): Event Report: Individual Shareholders’ Meeting Held On October 23, 2014 10/31/2014 8:49:38 AM
Cellectis (ALCLS): First-Half 2014 Financial Results 10/1/2014 9:36:35 AM
Cellectis Plant Sciences Launches Its New Website 9/29/2014 12:38:34 PM